Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company is having an Investors call with Duro Capital on the 13th of March, 2023. Krishna Institute of Medical Sciences Ltd - 543308 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyKrishna Institute of Medical Sciences Ltd 2CIN NO.L55101TG1973PLC040558 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 18.41 4Highest Credit Rating during the previous FY AA- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: UMASHANKAR MANTHA Designation: COMPANY SECRETARY EmailId: cs@kimshospitals.com Name of the Chief Financial Officer: VIKAS MAHESHWARI Designation: CFO EmailId: Vikas@kimshospitals.com Date: 08/03/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Buy Krishna Institute of Medical Sciences; target of Rs 1660: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Krishna Institute of Medical Sciences has recommended buy rating on the stock with a target price of Rs 1660 in its research report dated February 12, 2023. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Management of the Company will be meeting various Investors at a conference organized by IIFL Securities in Mumbai on the 16th of February, 2023. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
In Continuation to our letter dated 8th February 2023 the Company organized a conference call with the Investors/ Analysts on Friday, 10th February 2023 at 12:00 Noon (IST). A copy of the Transcript of the conference call held with the Investors/ Analysts is enclosed herewith and the same has also been uploaded on the Company''s Website Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
In Continuation to our letter dated 8th February 2023 the Company organized a conference call with the Investors/ Analysts on Friday, 10th February 2023 at 12:00 Noon (IST). A copy of the Transcript of the conference call held with the Investors/ Analysts is enclosed herewith and the same has also been uploaded on the Company''s Website Krishna Institute of Medical Sciences Ltd - 543308 - Result Of Postal Ballot By Remote E-Voting Process
Pursuant to the provisions of Section 110 of the Companies Act, 2013, read with the Companies (Management and Administration) Rules, 2014 as amended from time to time, the Company conducted the Postal Ballot as set out in the notice of Postal Ballot dated January 4, 2023. The remote e-voting process concluded at 5.00 p.m. (lST) on February 12, 2023, for which the scrutinizer submitted his report on the results of the postal ballot. Based on the report of the scrutinizer, we hereby inform you that the members of the Company have duly passed all the resolutions with the requisite majority. Pursuant to Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the details of the voting results enclosed as Annexure 1 and Scrutinizer''s Report on this behalf enclosed as Annexure 2 for your record.
Krishna Institute of Medical Sciences Results Earnings Call for Q3FY23
Conference Call with Krishna Institute of Medical Sciences Management and Analysts on Q3FY23 Performance and Outlook. Listen to the full earnings transcript. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 & 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to our Results conference call intimation dated February 8, 2023, please be informed that the Results conference call for Q3 FY23 was hosted on February 10, 2023 and the web link for the audio recording of the conference call, is available on the Company's website at https://www.kimshospitals.com/investors > Disclosures under Regulation 46 of SEBI (LODR) Regulations, 2015 > Analysts Calls schedule, PPT & Transcripts > Transcripts, Audio & Video Recordings > FY 22-23 Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the provisions of Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of the newspaper advertisement of the unaudited standalone and consolidated financial results of the company for the 3rd Quarter and nine months ended 31st December, 2022 published on 10th February, 2023 in Financial Express (English) and Navatelangana (Telugu).